| Literature DB >> 30518353 |
Gilad Twig1,2,3,4,5,6, Amir Tirosh7,8,9, Estela Derazne10,7, Ziona Haklai11, Nehama Goldberger11, Arnon Afek12,7, Hertzel C Gerstein13, Jeremy D Kark14, Tali Cukierman-Yaffe7,8,15.
Abstract
BACKGROUND: Epidemiological studies have demonstrated a relationship between cognitive function in youth and the future risk of death. Less is known regarding the relationship with diabetes related death. This study assessed the relationship between cognitive function in late adolescence and the risk for diabetes, cardiovascular- (CVD) and all-cause mortality in adulthood.Entities:
Keywords: Adolescence; Cognitive performance; Diabetes; Israelis; Mortality
Mesh:
Year: 2018 PMID: 30518353 PMCID: PMC6280532 DOI: 10.1186/s12933-018-0798-5
Source DB: PubMed Journal: Cardiovasc Diabetol ISSN: 1475-2840 Impact factor: 9.951
Fig. 1Flow diagram of study sample
Baseline characteristics of the study participants according to quintiles of general intelligence test scores
| Q1 | Q2 | Q3 | Q4 | Q5 | Total | p value for linear trend | |
|---|---|---|---|---|---|---|---|
| N of participants | 445,492 | 480,543 | 439,974 | 471,624 | 439,555 | 2,277,188 | |
| Female % | 31 | 43 | 44 | 44 | 40 | 40 | |
| Age ± SD | 17.4 ± 0.5 | 17.3 ± 0.4 | 17.3 ± 0.4 | 17.3 ± 0.4 | 17.3 ± 0.4 | 17.3 ± 0.4 | 0.158 |
| BMI ± SD (kg/m2) | 21.7 ± 3.6 | 21.7 ± 3.4 | 21.7 ± 3.3 | 21.6 ± 3.2 | 21.6 ± 3.1 | 21.6 ± 3.4 | 0.071 |
| Underweight % | 8.7 | 6.9 | 6.0 | 5.7 | 5.4 | 6.5 | 0.024 |
| Overweight % | 8.9 | 8.8 | 8.6 | 8.4 | 7.8 | 8.5 | 0.016 |
| Obese % | 4.9 | 4.0 | 3.5 | 3.3 | 3.0 | 3.7 | 0.011 |
| Height ± SD (males) | 171.8 ± 6.8 | 173.1 ± 6.8 | 173.6 ± 6.7 | 174.4 ± 6.7 | 175.1 ± 6.7 | 173.6 ± 6.8 | 0.001 |
| Height ± SD (females) | 160.9 ± 6.2 | 161.7 ± 6.1 | 162.0 ± 6.1 | 162.6 ± 6.0 | 163.1 ± 6.0 | 162.1 ± 6.1 | 0.001 |
| Completed high school education (%) | 56.9 | 76.3 | 82.1 | 91.0 | 96.0 | 80.5 | < 0.001 |
| Low SES % | 33 | 26 | 23 | 20 | 19 | 24 | 0.001 |
| Unimpaired health | 77.6 | 80.3 | 81.9 | 82.6 | 80.3 | 81.2 | 0.069 |
| Country of origin (%) | |||||||
| Israel | 4.6 | 5.0 | 5.7 | 6.4 | 7.6 | 5.8 | 0.003 |
| USSR | 9.0 | 10.9 | 11.8 | 14.7 | 16.1 | 12.5 | 0.001 |
| Asia | 30.6 | 29.5 | 26.6 | 21.9 | 16.0 | 25.0 | 0.007 |
| Africa | 38.1 | 30.8 | 24.5 | 17.8 | 11.8 | 24.7 | < 0.001 |
| Europe | 13.7 | 22.6 | 30.9 | 39.0 | 48.4 | 30.8 | < 0.001 |
| Ethiopia | 4.0 | 1.3 | 0.5 | 0.2 | 0.1 | 1.2 | 0.057* |
| Systolic/diastolic BP ± SD (mmHg) | 116.5 ± 12.2/71.8 ± 8.3 | 115.9 ± 12.2/71.8 ± 8.2 | 116.3 ± 12.3/71.6 ± 8.2 | 116.3 ± 12.2/71.7 ± 8.2 | 117.1 ± 12.3/71.7 ± 8.2 | 116.4 ± 12.2/71.7 ± 8.2 | 0.110/0.319 |
| Follow-up (mean ± SD) (years) | 19.0 ± 9.8 | 19.2 ± 8.9 | 20.0 ± 10.2 | 19.0 ± 9.7 | 18.9 ± 10.3 | 19.2 ± 9.8 | 0.821 |
| Median follow-up (25th; 75th) (years) | 18.8 (10.3, 28.7) | 18.9 (13.2, 27.0) | 19.7 (10.6, 32.0) | 18.9 (11.0, 29.3) | 19.9 (9.3, 30.1) | 19.2 (10.7, 29.5) | 0.759 |
| Cumulative follow-up (person-years) | 8,064,856 | 8,840,363 | 8,453,920 | 8,577,783 | 7,979,682 | 41,916,603 | 0.414 |
| Age at end of follow-up (± SD) | 37.0 ± 12.1 | 37.0 ± 11.0 | 38.4 ± 12.7 | 36.9 ± 11.9 | 36.9 ± 12.5 | 37.2 ± 12.0 | 0.907 |
* Exponential trend p < 0.001
The association between fifths of GIT scores and cause-specific mortality
| Mortality cause | Q1 | Q2 | Q3 | Q4 | Q5 | Total |
|---|---|---|---|---|---|---|
| a. | ||||||
| All-cause, N (%) | 8765 | 6306 | 6188 | 5221 | 4788 | 31,268 |
| Incidence (event/105 person-years) | 108.7 | 71.3 | 73.2 | 60.9 | 60.0 | 74.6 |
| Total cardiovascular, N (%) | 1075 | 641 | 624 | 394 | 334 | 3068 |
| Incidence (event/105 person-years) | 13.3 | 7.25 | 7.4 | 4.6 | 4.2 | 7.3 |
| Coronary heart disease, N (%) | 526 | 288 | 308 | 165 | 156 | 1443 |
| Incidence (event/105 person-years) | 6.5 | 3.3 | 3.6 | 1.9 | 1.9 | 3.4 |
| Stroke, N (%) | 172 | 115 | 110 | 72 | 45 | 514 |
| Incidence (event/105 person-years) | 2.1 | 1.3 | 1.3 | 0.8 | 0.6 | 1.2 |
| Diabetes, N (%) | 184 | 98 | 96 | 51 | 28 | 457 |
| Incidence (event/105 person-years) | 2.3 | 1.1 | 1.1 | 0.6 | 0.4 | 1.1 |
| Non-CVD, non-diabetes, N (%) | 7506 | 5567 | 5468 | 4776 | 4426 | 27,743 |
| Incidence (event/105 person-years) | 93.1 | 63.0 | 64.7 | 55.7 | 55.4 | 66.2 |
| b. | ||||||
| All cause | 1.84 | 1.25 | 1.21 | 1.04 | 1 | 4.10*10−231 |
| All cause | 1.23 | 1.08 | 1.04 | 1.01 | 1 | 1.3*10−33 |
| Total CVD (unadjusted) | 3.32 | 1.92 | 1.71 | 1.15 | 1 | 2.13*10−126 |
| Total CVD | 1.76 | 1.44 | 1.27 | 1.05 | 1 | 1.3*10−14 |
| CHD | 3.49 | 1.87 | 1.8 | 1.03 | 1 | 1.21*10−66 |
| CHD | 1.70 | 1.36 | 1.31 | 0.95 | 1 | 1.6*10−9 |
| Stroke | 3.96 | 2.60 | 2.22 | 1.56 | 1 | 5.06*10−24 |
| Stroke | 2.03 | 1.83 | 1.61 | 1.40 | 1 | 3.3*10−6 |
| Diabetes | 6.96 | 3.76 | 3.08 | 1.81 | 1 | 5.13*10−38 |
| Diabetes | 3.14 | 2.36 | 2.04 | 1.55 | 1 | 3.2*10−9 |
| Non CVD/diabetes | 1.70 | 1.18 | 1.16 | 1.02 | 1 | 7.78*10−247 |
| Non CVD/diabetes | 1.17 | 1.04 | 1.01 | 1.01 | 1 | 1.3*10−19 |
The association between fifths of GIT scores (in comparison to highest quintile) and cause of death was determined using unadjusted and after adjustment for age, sex, birth year, body mass index (BMI), residential socioeconomic status, education and country of origin
HR Hazard ratio, CI confidence interval, CHD coronary heart disease, CVD cardiovascular
Fig. 2Cox hazard ratios for mortality due to all cardiovascular disease, coronary heart disease, stroke, diabetes, and all-cause mortality for the highest GIT quintile in comparison to lower quintiles after multivariable adjustment for age, sex, birth year, BMI, residential SES, education and country of origin (Model 4)
Fig. 3Cox hazard ratios for the relationship between a 1 unit lower GIT z-score on an interval scale and cause-specific mortality (all cardiovascular disease, CHD, stroke, diabetes, and all-cause mortality) in sequentially-adjusted models: age, birth year and sex (Model 1); these and BMI (Model 2); these and residential SES (Model 3); these and education and country of origin (Model 4)